Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Amcasertib |
Trade Name | |
Synonyms | BBI-503|BBI503 |
Drug Descriptions |
Amcasertib (BBI503) is a kinase inhibitor that inhibits signaling pathways that regulate survival of cancer stem cells, resulting in decreased cancer cell growth (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | 1129403-56-0 |
NCIT ID | C104745 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Amcasertib | Amcasertib | 0 | 6 |
Amcasertib + Sorafenib | Amcasertib Sorafenib | 0 | 1 |